Dr. Mastura Md Yusof Medical Oncology

Dr. Mastura Md Yusof is among the top medical oncologist in Kuala Lumpur, Malaysia.

Dr. Mastura Md Yusof’s area of expertise in clinical oncology encompasses radiation therapy, medical oncology and cancer palliation as well as clinical research in breast, colorectal and gastrointestinal cancers and various cancer sites.

For her outstanding work and efforts, Dr Mastura was awarded the Universiti Malaya Excellent award for 2014. Dr Mastura serves as consultant in various advisory boards and expert committee panels for cancer and cancer-related services in government such as good oncology practice and chemotherapy protocol guideline, as well as in private sectors.

Dr Mastura is currently an EXCO member of the Malaysian Oncological Society and a member of the Academy of Medicine Malaysia (AM), European Society of Medical Oncology, American Society of Clinical Oncology and European Society for Therapeutic Radiology and Oncology. She has worked and shared her expertise with NGOs championing cancer awareness, early diagnosis and treatment within Malaysia and South East Asia.

• Brain Tumours
• Breast Cancer
• Colorectal Cancer
• Germ Cell Tumours
• Gynaecological Cancers
• Kidney Cancer
• Liver Cancer
• Lung Cancer
• Pancreatic Cancer
• Prostate Cancer
• Bladder
• Benign Disease-Keloid
• Skin Cancer
• Neuroendocrine Cancer
• Head & Neck Cancer
• Sarcoma
• Gastrointestinal Stromal Tumors (GISTs)
• Nasopharyngeal Cancer
• Thyroid Cancer
• Gastric/ Upper GI
• Esophageal Cancer

• Multidisciplinary Cancer Management
• Systemic Therapy (Intravenous / Oral Chemotherapy, Targeted Therapies, Immunotherapy, Biological Therapy, Hormone Therapy)
• Cancer Management in Pregnancy
• Radiotherapy (Conformal Radiotherapy, Palliative Radiotherapy, High Dose Rate Brachytherapy, Intensive Modulated Radiotherapy/Image Guided RT, Radioiodine Therapy, Stereotactic Body Radiotherapy, IORT)
• Palliative Care (Basic Palliative Care & Cancer Pain Management)
• Clinical Trials/ Clinical Research
• Cancer Palliation

1) The efficacy and tolerability of scalp cooling in preventing chemotherapy-induced alopecia in patients with breast cancer receiving anthracycline and taxane-based chemotherapy in an Asian setting. Saad M, Chong FL, Bustam AZ, Ho GF, Malik RA, Ishak WZ, et al. Indian J Cancer 2018; published January 2019

2) Yip CH, Yusof M, Abdullah MM, Foo YC, Yap BK, et al. The role of neoadjuvant chemotherapy in the surgical management of women with breast cancer in a middle-income country. Adv Mod Oncol res 2017; 3(s1) xx–xx.doi: 10.18282/amor.v3.is1.197

3) Dorothy Keefe, Abdullah Al Garni, Antonio Villalon, Azza Hassan, Dora Kwong, Pingping Li, Kazuo Tamura, Jee Hyun Kim, Mastura Md Yusof, Muhammad Zafar Javed, RavindranKanesvaran, Ruey-Kuen Hsieh, Matti AaproChallenges in supportive cancer care: perspectives from the Asia Pacific and Middle East, Supportive Care in Cancer August 2016

4) Mastura Md Yusof*, Nik MA Abdullah, MSN Mohd Sharial, Adel Zaatar Safety and Management of Toxicity Related to Aflibercept in Combination with Fluorouracil, Leucovorin and Irinotecan in Malaysian Patients with Metastatic Colorectal Cancer, Asian Pac J Cancer Prev, 17 (3), 973-978

5) Yoke Fui Wong, Mastura Md Yusof, Wan Zamaniah Wan Ishak, Adlinda Alip, Vincent Chee Ee Phua*Treatment Outcome for Head and Neck Squamous Cell Carcinoma in a Developing Country: University Malaya Medical Centre, Malaysia from 2003-2010 Asian Pacific Journal of Cancer Prevention, Vol 16, 2015 2904

6) M.Y. Mastura, S. Marniza, W.I. Wan Zamaniah, P. Vincent, A.M. Rozita, A. Adlinda, G.F. Ho. P0140 Second line aflibercept/folfiri chemotherapy in metastatic colorectal cancer in a single institution in a south east asian country: A case series. European Journal of Cancer 05/2014; 50:e48-e49.

Employment Challenges Faced by Breast Cancer Survivors in an Upper Middle–Income Asian Setting , Y-C Kong1, N.T. Bhoo-Pathy2, L.-P. Wong2, A.F. Aziz3, N.A. Taib4, P. Yehgambaram5, M. Md. Yusof3, S. Subramaniam1, C.-H. Yip6, N. Bhoo-Pathy2 Journal of Global Oncology 4, No Supplement 2
7) CE Phua, WH Tang, MM Yusof, M Saad, A Alip, MH See, NA Taib, Risk of Treatment Related Death and Febrile Neutropaenia with First Line Palliative Chemotherapy for De Novo Metastatic Breast Cancer in Clinical Practice in a Middle Resource Country. Asian Pacific Journal of Cancer Prevention VOLUME 15, 2014 Issue Number 23 , 10263-10266